Product image of Levetiracetam Rudipharm (Levetiracetam) supplied by GNH India

Levetiracetam Rudipharm

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Rudipharm (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Rudipharm, is an antiepileptic presented as a tablet for oral use. It is prescribed to manage various seizure types in adults and children with epilepsy.

GNH India supplies Levetiracetam Rudipharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets, and providing reliable logistics for timely delivery.

Manufacturer / TM Owner

Rudipharm Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levetiracetam is an antiepileptic drug used to control seizures across several epilepsy syndromes.

  • Partial‑onset seizures: reduces the frequency of focal seizures in patients with epilepsy.
  • Generalized tonic‑clonic seizures: helps prevent convulsive episodes in both adults and children.
  • Myoclonic seizures: diminishes rapid, involuntary muscle jerks associated with juvenile myoclonic epilepsy.

How It Works

  • Levetiracetam binds to the synaptic vesicle protein SV2A, a key regulator of neurotransmitter release. This interaction modulates synaptic vesicle exocytosis, leading to reduced neuronal excitability and stabilization of hyper‑active neuronal circuits that underlie seizure generation.

Side Effects

Levetiracetam may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Dizziness: transient sensation of light‑headedness.
  • Somnolence: increased sleepiness or fatigue.
  • Irritability: mood changes such as agitation.
  • Headache: mild to moderate cranial pain.
  • Nausea: occasional stomach upset.
  • Fatigue: reduced energy levels.

Serious or Rare Side Effects

  • Severe allergic reactions: including Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Mood disturbances: depression, suicidal thoughts, or aggressive behavior.
  • Hematologic abnormalities: thrombocytopenia or leukopenia.
  • Multi‑organ hypersensitivity: systemic rash with fever and organ involvement.
  • Severe skin reactions: bullous pemphigoid‑like eruptions.
  • Respiratory depression: when combined with other CNS depressants.

Precautions & Warnings

When prescribing Levetiracetam, clinicians should consider several safety measures and patient‑specific factors.

  • Renal impairment: adjust dose based on creatinine clearance.
  • History of psychiatric disorders: monitor mood and behavior closely.
  • Concomitant CNS depressants: observe for enhanced sedation.
  • Pregnancy: evaluate risk‑benefit; limited safety data are available.
  • Store at room temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Levetiracetam can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid)

  • Carbamazepine: may reduce levetiracetam plasma concentrations.
  • Phenobarbital: can decrease exposure and seizure control.
  • Phenytoin: may lower levetiracetam levels.
  • Rifampin: induces metabolism, reducing effectiveness.
  • Other enzyme inducers: avoid co‑administration without monitoring.

Moderate Interactions (Monitor Closely)

  • Alcohol: additive central nervous system depression.
  • Sedative antihistamines: increased drowsiness.
  • Opioids: enhanced respiratory depression risk.
  • Valproate: monitor overall seizure control.
  • Hormonal contraceptives: may reduce efficacy, advise alternative methods.

Frequently Asked Questions

Levetiracetam Rudipharm is used to treat epilepsy. It is indicated for partial‑onset seizures, generalized tonic‑clonic seizures, and myoclonic seizures, helping to reduce the frequency and severity of seizure episodes in both adult and pediatric patients.

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. By influencing this protein, the drug stabilizes neuronal firing and lowers excessive excitability that can trigger seizures.

The dosage of Levetiracetam Rudipharm is individualized. A qualified prescriber determines the appropriate amount based on the patient’s age, weight, renal function, and seizure type, following current clinical guidelines.

Safety data for levetiracetam in pregnancy and lactation are limited. Prescribers should weigh potential benefits against risks, discuss alternatives, and monitor the mother and infant closely if the medication is continued.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a favorable safety profile and minimal drug‑enzyme interactions compared with many older antiepileptics such as carbamazepine or phenytoin. It is often chosen for its broad spectrum of activity and ease of dosing, though individual response varies.

Store the product at room temperature, below 25 °C, in the original packaging. Protect it from moisture and direct sunlight to maintain stability and potency throughout its shelf life.

Levetiracetam Rudipharm is taken orally, usually as a tablet. It can be swallowed whole with water, and may be taken with or without food according to the prescriber’s instructions.

Serious risks include severe allergic reactions such as Stevens‑Johnson syndrome, significant mood changes including depression or suicidal thoughts, and rare hematologic abnormalities. Patients should seek immediate medical attention if they notice rash, mood swings, or unexplained bruising.

Patients with known hypersensitivity to levetiracetam or any of its excipients should avoid the product. Caution is also advised for individuals with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting enzyme‑inducing medications without proper monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT